Graham François, Waserman Susan, Gerdts Jennifer, Povolo Beatrice, Bonvalot Yvette, La Vieille Sébastien
Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC H2X 0C1, Canada.
Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC H3T 1C5, Canada.
Nutrients. 2025 Apr 30;17(9):1556. doi: 10.3390/nu17091556.
Despite the widespread use of precautionary allergen labelling (PAL) by manufacturers, PAL is not always used consistently and can be a source of misinterpretation by consumers and allergists. Although its use is not specifically regulated in Canada, some voluntary guidelines exist. The aims of this study were to investigate allergic consumers' and clinicians' understanding of PAL, to describe consumers' attitudes towards products with PAL, and to examine recommendations given by clinicians to their patients about these products. We also compared two groups of consumers enrolled in this study, since the majority of them (72%) were registered in the Food Allergy Canada database and the others (28%) came from representative consumers of the general population.
An online survey was sent from 2 to 28 December 2021 to allergic consumers registered with Food Allergy Canada's database and to a group of allergic consumers extracted from a panel representative of the general population and not registered with Food Allergy Canada (third-party panel). All consumer participants had a food allergy or were a parent/caregiver of a child with food allergy and had to be diagnosed by a medical professional. Considering that consumers registered via the Food Allergy Canada database could be more informed about labelling than the third-party consumer panel, we conducted a multivariate analysis (logistic regression) on the key variables related to PAL allowing to compare these two groups of participants. In addition, a separate online survey was sent to allergist members of the Canadian Society of Allergy and Clinical Immunology and provincial associations to investigate their understanding of PAL from 12 November 2021 to 16 January 2022.
A total of 1080 consumers and 63 allergists (29% of allergists in Canada) responded to the surveys. Fifty percent of consumers were adults with food allergy, and 50% were a parent/caregiver of a child with food allergy. Food allergy was diagnosed most commonly by an allergist in 76% of the cases. Fifty-four percent of consumers purchased products with a PAL statement at least occasionally, and more than half of consumers (53%) considered PAL a very useful tool. Most surveyed individuals (59%) had not heard of the term "individual allergen threshold" or had heard the term but did not know what it meant. The same allergic consumers were reluctant to buy food products with even a small amount of their allergen (i.e., a dose that would not trigger an allergic reaction in the vast majority of them). Half of allergists reported PAL was not useful in its current form, and 83% supported the consumption of foods with PAL to their patients in some circumstances.
While most consumers are somewhat confident in the accuracy of ingredient information on pre-packaged foods, interpretation of PAL remains confusing by many allergic consumers. If changes are to be made based on allergen thresholds, a multi-stakeholder approach will be required with greater consumer and allergist education on risk assessment concepts to facilitate the implementation of allergen population thresholds into the application of PAL.
尽管制造商广泛使用预防性过敏原标签(PAL),但PAL的使用并不总是一致的,可能会被消费者和过敏症专科医生误解。尽管在加拿大其使用没有具体的监管规定,但存在一些自愿性指南。本研究的目的是调查过敏消费者和临床医生对PAL的理解,描述消费者对带有PAL的产品的态度,并检查临床医生给患者关于这些产品的建议。我们还比较了参与本研究的两组消费者,因为他们中的大多数(72%)注册在加拿大食物过敏数据库中,其余(28%)来自一般人群的代表性消费者。
2021年12月2日至28日,向注册在加拿大食物过敏数据库中的过敏消费者以及从一般人群代表性小组中提取的、未注册在加拿大食物过敏数据库中的一组过敏消费者(第三方小组)发送了在线调查问卷。所有消费者参与者都患有食物过敏或为患有食物过敏儿童的父母/照顾者,并且必须由医学专业人员诊断。考虑到通过加拿大食物过敏数据库注册的消费者可能比第三方消费者小组更了解标签,我们对与PAL相关的关键变量进行了多变量分析(逻辑回归),以便比较这两组参与者。此外,2021年11月12日至2022年1月16日,向加拿大过敏与临床免疫学会和省级协会的过敏症专科医生成员发送了一份单独的在线调查问卷,以调查他们对PAL的理解。
共有1080名消费者和63名过敏症专科医生(占加拿大过敏症专科医生的29%)回复了调查。50%的消费者是患有食物过敏的成年人,50%是患有食物过敏儿童的父母/照顾者。在76%的病例中,食物过敏最常由过敏症专科医生诊断。54%的消费者至少偶尔购买带有PAL声明的产品,超过一半的消费者(53%)认为PAL是一个非常有用的工具。大多数接受调查的人(59%)没有听说过“个体过敏原阈值”这个术语,或者听说过但不知道是什么意思。同样这些过敏消费者甚至不愿意购买含有少量他们的过敏原的食品(即,在绝大多数情况下不会引发过敏反应的剂量)。一半的过敏症专科医生报告称PAL目前的形式没有用,83%的人在某些情况下支持向他们的患者推荐食用带有PAL的食品。
虽然大多数消费者对预包装食品成分信息的准确性有一定信心,但许多过敏消费者对PAL的解读仍然感到困惑。如果要根据过敏原阈值做出改变,将需要采取多利益相关方的方法,对消费者和过敏症专科医生进行更多关于风险评估概念的教育,以促进将过敏原群体阈值应用于PAL的实施。